Comment on

• DUR: good systems provide assistance, not annoyance.

  Winckler SC. Winckler SC. J Am Pharm Assoc (Wash). 2000 Jul-Aug;40(4):462-3. J Am Pharm Assoc (Wash). 2000. PMID: 10932453 No abstract available.
• Drug utilization review of sedative/hypnotic agents in Texas Medicaid patients. Texas Medicaid Vendor Drug Program Drug Utilization Review Board.

  Seltzer JK, Kurt TL, Knodel LC, Dean B, Burch C. Seltzer JK, et al. J Am Pharm Assoc (Wash). 2000 Jul-Aug;40(4):495-9. J Am Pharm Assoc (Wash). 2000. PMID: 10932458
• Effect of patient information on the quality of pharmacists' drug use review decisions.

  Warholak-Juarez T, Rupp MT, Salazar TA, Foster S. Warholak-Juarez T, et al. J Am Pharm Assoc (Wash). 2000 Jul-Aug;40(4):500-8. J Am Pharm Assoc (Wash). 2000. PMID: 10932459
• Drug utilization review: mechanisms to improve its effectiveness and broaden its scope. The U.S. Pharmacopeia Drug Utilization Review Advisory Panel.

  [No authors listed] [No authors listed] J Am Pharm Assoc (Wash). 2000 Jul-Aug;40(4):538-45. J Am Pharm Assoc (Wash). 2000. PMID: 10932464 Review.